ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0743

Home-Based Telehealth in Rheumatology: A Systematic Review & Narrative Synthesis

Alexander Peck1, Rebecca Grainger2, Jeffrey Curtis3, John Cush4, Neelkamal Soares5, Nikhil Davuluri6, William Benjamin Nowell7, Sandeep Sodhi8, Danielle Grauer8, Natalie Fortune6, Shilpa Venkatachalam9, Daniel Kirby10, Jeffrey Alper11, Kelly Gavigan12, Laura Stradford7, David Curtis12 and Swamy Venuturupalli1, 1Cedars-Sinai Medical Center, Los Angeles, CA, 2University of Otago, Wellington, New Zealand, 3Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 4RheumNow, Dallas, TX, 5Western Michigan University, Kalamazoo, MI, 6Attune Health, Beverly HIlls, CA, 7Global Healthy Living Foundation, Nyack, NY, 8Illumination Health, Birmingham, AL, 9Global Healthy Living Foundation, New York, NY, 10Bendcare, Charlotte, NC, 11Bendcare, Naples, 12Global Healthy Living Foundation, Upper Nyack, NY

Meeting: ACR Convergence 2022

Keywords: Access to care, autoimmune diseases, Health Services Research

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Health Services Research Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Home based telehealth (HBT) visits, where a patient is located at home with a remote provider, became common during the COVID-19 pandemic. Patients now request HBT, even though in-person visits are possible. We conducted a systematic literature search with narrative synthesis on the use of HBT in rheumatology with the aim of informing the clinical practice of rheumatology using HBT.

Methods: We searched Cochrane, PubMed, and Web of Science databases using a pre-defined search strategy (Figure 1). A total of 2269 articles were retrieved and then subjected to further review (Figure 2). Two independent reviewers assessed whether the articles specifically addressed our objectives of determining HBT suitability, choosing telehealth-appropriate disease outcome measures, and identifying instruments suitable for measuring patient acceptance of HBT. Data was then extracted for a narrative summary and gap analysis.

Results: Seventeen studies and four abstracts met inclusion criteria and were included in the synthesis. Study heterogeneity precluded a meta-analysis. The key findings were as follows: Two studies support the use of pre-visit triage for new patients with inflammatory back pain and for early inflammatory arthritis by using telephone survey tools and enrolling Spondyloarthropathy patients for inflammatory back pain and rheumatologist-diagnosed inflammatory arthritis patients as control groups, respectively. Two survey studies reported providers had good acceptance of HBT for stable patients compared to more active patients or more complex presentations. Four studies reported successful use of remotely collected disease activity measures and PROs and reported concordance between PROs (RAID and RAPID3) with DAS-28 in low disease activity but not higher disease activity states. Another study supported the use of protocolized serum uric acid management in gout via telehealth visits. Two studies examined reported that telehealth satisfaction was generally high but was lower with increasing patient age.

Conclusion: A systematic literature search for articles addressing HBT in rheumatology provides useful, albeit limited, data as to how HBT can safely and effectively complement in-person care for certain rheumatologic conditions, particularly inflammatory arthritis, and gout. The data also provides some guidance on the appropriate selection of patients for telehealth. Further, the data highlights key gaps that future research should address such as creating strategies to identify patients whose health needs can be adequately addressed by HBT and optimizing methods to collect PROs and disease activity measures during HBT.

Supporting image 1

Figure 1: Search Strategy used to Retrieve Telehealth Articles

Supporting image 2

Figure 2: Process Used to Retrieve Relevant Articles & Abstracts


Disclosures: A. Peck, None; R. Grainger, AbbVie/Abbott, Janssen, Novartis, Pfizer, Cornerstones; J. Curtis, Amgen, Bristol-Myers Squibb (BMS), CorEvitas, IlluminationHealth, Janssen, Lilly, Myriad, Novartis, Pfizer, Sanofi, UCB, Aqtual, Bendcare, FASTER, GlaxoSmithKlein (GSK), Labcorp, Scipher, Setpoint, United Rheumatology, AbbVie, ArthritisPower; J. Cush, None; N. Soares, None; N. Davuluri, None; W. Nowell, Global Healthy Living Foundation, AbbVie Inc., Amgen, Eli Lilly; S. Sodhi, None; D. Grauer, None; N. Fortune, None; S. Venkatachalam, None; D. Kirby, None; J. Alper, None; K. Gavigan, None; L. Stradford, Global Healthy Living Foundation; D. Curtis, Global Healthy Living Foundation; S. Venuturupalli, Horizon Pharma USA, Inc., Kezar Life Sciences, Inc., Mallinckrodt, Inc., Navidea Biopharmaceuticals, Inc., Pfizer (Current), Bristol-Myers Squibb(BMS), Argenx, Janssen.

To cite this abstract in AMA style:

Peck A, Grainger R, Curtis J, Cush J, Soares N, Davuluri N, Nowell W, Sodhi S, Grauer D, Fortune N, Venkatachalam S, Kirby D, Alper J, Gavigan K, Stradford L, Curtis D, Venuturupalli S. Home-Based Telehealth in Rheumatology: A Systematic Review & Narrative Synthesis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/home-based-telehealth-in-rheumatology-a-systematic-review-narrative-synthesis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/home-based-telehealth-in-rheumatology-a-systematic-review-narrative-synthesis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology